Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Page

Showing results (451-460 of 511) with videos related to

Pageof 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung CancerNatasha B Leighl, Ray D Page, Victoria M Raymond, et al.
JCO Oncology Practice|June 21, 2021
Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task ForceFay J Hlubocky, Anthony L Back, Tait D Shanafelt, et al.
The New England Journal of Medicine|February 21, 2009
Estimation of the warfarin dose with clinical and pharmacogenetic data, T E Klein, R B Altman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.
Clinical Lung Cancer|November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung CancerRay D Page, Leylah M Drusbosky, Hiba Dada, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2024
Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulationShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Lung Cancer (Auckland, N.Z.)|November 16, 2017
<i>nab</i>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapyMichael Thomas, David R Spigel, Robert M Jotte, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
Pageof 52

Showing results (451-460 of 511) with videos related to

Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung CancerNatasha B Leighl, Ray D Page, Victoria M Raymond, et al.
JCO Oncology Practice|June 21, 2021
Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task ForceFay J Hlubocky, Anthony L Back, Tait D Shanafelt, et al.
The New England Journal of Medicine|February 21, 2009
Estimation of the warfarin dose with clinical and pharmacogenetic data, T E Klein, R B Altman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.
Clinical Lung Cancer|November 16, 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung CancerRay D Page, Leylah M Drusbosky, Hiba Dada, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2024
Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulationShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Lung Cancer (Auckland, N.Z.)|November 16, 2017
<i>nab</i>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapyMichael Thomas, David R Spigel, Robert M Jotte, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
Pageof 52